Citation data

CrossRef

Works that cite this article, indexed by Crossref.

14 resultsUpdated August 09, 2026
1

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort

BMC Nephrology 16(1) (2015)

Luciana Sowole; Wendy Labbett; Mauli Patel; Aisling O’Riordan; Jennifer Cross; Andrew Davenport; Tanzina Haque

2

Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China

Expert Review of Vaccines 21(11) (2022)

Yujie Han; Na Cao; Xiaoxiao Lu; Tian Yao; Jing Shi; Yuanting Wu; Shuang Dong; Zhihong Shao; Jianmin Wang; Hongting Liu; Hongping Guo; Guowei Chai; Liming Liu; Fuzhen Wang; Yongliang Feng; Xiaofeng Liang; Suping Wang

3

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure

Hepatitis Monthly 13(3) (2013)

Zahra Khazaeipour; Farokhlagha Ahmadi

4

Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines

Expert Review of Vaccines 13(11) (2014)

Alicja E Grzegorzewska

5

Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial

Expert Review of Vaccines 20(6) (2021)

Yongliang Feng; Tian Yao; Yujie Han; Jing Shi; Shuang Dong; Yuanting Wu; Zhihong Shao; Hongting Liu; Hongping Guo; Guowei Chai; Liming Liu; Fuzhen Wang; Jianmin Wang; Xiaofeng Liang; Suping Wang

6

Seroprotection achieved with standard four-dose schedule of hepatitis B vaccine in people with chronic kidney disease: A real-life data

Indian Journal of Gastroenterology 44(1) (2025)

Surender Singh; Ajay Kumar Mishra; Monika Yachha; Thakur Prashant Singh; Harshita Katiyar; Anupma Kaul; Radha Krishna Dhiman; Dharmendra Singh Bhadauria; Amit Goel

7

Barriers to vaccination in renal transplant recipients

Transplant Infectious Disease 19(5) (2017)

Angela Q. Maldonado; David Johnson; Jennifer Trofe‐Clark

8

Variables linked to hepatitis B vaccination success in non-dialyzed chronic kidney disease patients: Use of a bayesian model

Néphrologie & Thérapeutique 15(4) (2019)

Yves Dimitrov; Michel Ducher; Marc Kribs; Guillaume Laurent; Sarah Richter; Jean-Pierre Fauvel

10

Immunogenicity, Safety, and Persistence Induced by Triple- and Standard-Strength 4-Dose Hepatitis B Vaccination Regimens in Patients Receiving Hemodialysis

The Journal of Infectious Diseases 231(4) (2025)

Tian Yao; Yandi Li; Yidan Zhang; Yangle Sun; Yana Guo; Jianmin Wang; Xiaohui Song; Wei Zhang; Baozhu Wei; Jingen Bai; Hui Wang; Weimin Yu; Huiyuan Wang; Lu Jiao; Yinqiang Diao; Liming Liu; Shuaishuai Shi; Jie Yang; Xiaojun Ren; Wenyuan Liu; Jingai Fang; Xiaofeng Liang; Suping Wang; Yongliang Feng

11

Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

Expert Review of Vaccines 16(10) (2017)

Yongliang Feng; Xiaohong Shi; Jing Shi; Linying Gao; Guangming Liu; Yanpeng Cheng; Minghu Pan; Chunxia Li; Jun Wang; Xuxia Guo; Yawei Zhang; Xiaofeng Liang; Suping Wang

12

Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease Clinic

Infectious Disease Reports 13(4) (2021)

Jacob Hettenbaugh; Ryan Mullane; Gayle Gillispie; Valerie Shostrom; Linda Flores; Jennifer A. Fillaus; Marius C. Florescu; Denise Murcek; Ketki K. Tendulkar

14

Decreasing High Failure Rate of Vaccinations in Patients With Chronic Kidney Disease; not Just a Matter of Quantity

Hepatitis Monthly 12(7) (2012)

Theodoros Eleftheriadis; Vassilios Liakopoulos; Ioannis Stefanidis